ArticleBreast cancer research : BCR2023

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.

Xi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.